An mRNA vaccine for avian influenza, developed by pharma company Moderna, has begun Phase 3 human trials. Building on the ...

The Department of Health and Human Services had canceled hundreds of millions of dollars in funding previously committed help ...

The treatment staved off cancer for seven of eight patients with a condition where the odds are rarely that good.

One of the beneficial characteristics of the response to the COVID -19 pandemic were pledges from companies involved in developing vaccines (such as Moderna, Pfizer, BioNTech, and others) not to ...

Indian American physician-scientist Dr. Vinod Balachandran says mRNA vaccines may reduce risk of disease coming back after ...

The U.S. Food and Drug Administration (FDA) is reviewing a new flu vaccine for adults age 50 and older. If approved, it would be the first influenza shot to use mRNA technology, and experts say it ...

A recent clinical trial using an mRNA vaccine helped to greatly extend the lives of people with pancreatic cancer and a new ...

In vitro transcribed mRNA has lived up to its potential as a game-changing disruptive vaccine modality during the COVID-19 ...

A program that got caught up in HHS’ decision to abandon mRNA research was revived by a public-private coalition and is now ...

Bird flu mRNA vaccine advances to Phase 3 testing with 4,000 participants. Discover how Moderna's H5N1 vaccine could ...

German biotech firm CureVac has filed a lawsuit against Moderna in Delaware, alleging patent infringement of its mRNA technology in Moderna's COVID-19 vaccine, Spikevax. The case is among several ...

Investing.com - German biotech company CureVac sued Moderna (NASDAQ:MRNA) in Delaware federal court on Friday, alleging that Moderna’s COVID-19 vaccine Spikevax infringed CureVac patents related to ...